Eric Hsu

2024

In 2024, Eric Hsu earned a total compensation of $322.5K as Senior Vice President, Preclinical Research & Development at InMed Pharmaceuticals, a 24% increase compared to previous year.

Compensation breakdown

Bonus$45,700
Option Awards$15,800
Salary$261,000
Total$322,500

Hsu received $261K in salary, accounting for 81% of the total pay in 2024.

Hsu also received $45.7K in bonus and $15.8K in option awards.

Rankings

In 2024, Eric Hsu's compensation ranked 123rd out of 152 executives tracked by ExecPay. In other words, Hsu earned more than 19.1% of executives.

ClassificationRankingPercentile
All
123
out of 152
19th
Division
Manufacturing
54
out of 66
18th
Major group
Chemicals And Allied Products
22
out of 26
15th
Industry group
Drugs
22
out of 26
15th
Industry
Pharmaceutical Preparations
20
out of 23
13th
Source: SEC filing on October 28, 2024.

Hsu's colleagues

We found five more compensation records of executives working with Eric Hsu at InMed Pharmaceuticals in 2024.

2024

Eric Adams

InMed Pharmaceuticals

Chief Executive Officer

2024

Michael Woudenberg

InMed Pharmaceuticals

Chief Operating Officer

2024

Alexandra Mancini

InMed Pharmaceuticals

Senior Vice President, Clinical & Regulatory Affairs

2024

Netta Jagpal

InMed Pharmaceuticals

Chief Financial Officer

2024

Jonathan Tegge

InMed Pharmaceuticals

Chief Financial Officer

News

You may also like